CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 49 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2019. The put-call ratio across all filers is 8.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $145,000 | – | 50,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
| BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
| Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
| WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
| Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
| XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
| Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
| Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
| SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |